CHANGES IN PLASMA GROWTH HORMONE LEVELS IN RETARDED CHILDREN

2008 ◽  
Vol 12 (3-4) ◽  
pp. 294-306
Author(s):  
J. HILLMAN ◽  
J. HAMMOND ◽  
J. SOKOLA ◽  
M. REISS
Keyword(s):  
Growth Hormone ◽  
Plasma Growth Hormone ◽  
Hormone Levels

scholarly journals Normalisation of plasma growth hormone levels improved cardiac dysfunction due to acromegalic cardiomyopathy with severe fibrosis

2010 ◽  
Vol 2010 (oct18 2) ◽  
pp. bcr1220092559-bcr1220092559 ◽  
Author(s):  
F. Yokota ◽  
H. Arima ◽  
M. Hirano ◽  
T. Uchikawa ◽  
Y. Inden ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Cardiac Dysfunction ◽  
Plasma Growth Hormone ◽  
Hormone Levels ◽  
Acromegalic Cardiomyopathy ◽  
Severe Fibrosis

Pituitary and Plasma Growth Hormone Levels in Bulls from Birth to One Year of Age

1970 ◽  
Vol 31 (2) ◽  
pp. 358-363 ◽  
Author(s):  
R. W. Purchas ◽  
K. L. Macmillan ◽  
H. D. Hafs
Keyword(s):  
Growth Hormone ◽  
Plasma Growth Hormone ◽  
Hormone Levels ◽  
One Year

Sustained exercise augments long-term starvation increases in plasma growth hormone in the steelhead trout, Salmo gairdneri

1988 ◽  
Vol 66 (4) ◽  
pp. 853-855 ◽  
Author(s):  
Bruce A. Barrett ◽  
Brian A. McKeown
Keyword(s):  
Growth Hormone ◽  
Salmo Gairdneri ◽  
Steelhead Trout ◽  
Hormone Concentration ◽  
Plasma Growth Hormone ◽  
Hormone Levels ◽  
Significant Difference ◽  
Normal Feeding ◽  
Stored Reserves

During the increased locomotor activity of migration many salmonids do not actively feed and it is likely that metabolic alterations occur to facilitate the mobilization of stored reserves. The present laboratory study was designed to simulate the occurrence of exercise and starvation as natural parameters of migration and to assess the effects of such parameters on levels of plasma growth hormone, which might indicate alterations in metabolism during migration. Juvenile steelhead trout, Salmo gairdneri, were starved for a 30-day period. Starved individuals exhibited a marked increase in plasma growth hormone concentration (38.6 ± 6.7 ng/mL) compared with control individuals held on a normal feeding regime (6.4 ± 1.84 ng/mL). A subgroup of fish from the starved group were exercised by being forced to swim at 1.5 body lengths/s for a 24-h period. Exercised individuals exhibited plasma growth hormone levels in excess of 140 ng/mL. There was no significant difference between the plasma growth hormone levels of unexercised starved fish and exercised fed fish.

DIFFERENT EFFECTS OF EXOGENOUS CYCLIC ADENOSINE MONOPHOSPHATE AND ITS DIBUTYRYL DERIVATIVE ON PLASMA GROWTH HORMONE, GLUCOSE, INSULIN AND CORTISOL

1976 ◽  
Vol 83 (1) ◽  
pp. 15-25
Author(s):  
M. Vanderschueren-Lodeweyckx ◽  
W. Proesmans ◽  
E. Eggermont ◽  
R. Eeckels
Keyword(s):  
Growth Hormone ◽  
Hormone Secretion ◽  
Growth Hormone Secretion ◽  
Cyclic Adenosine Monophosphate ◽  
Adenosine Monophosphate ◽  
Normal Subjects ◽  
Immunoreactive Insulin ◽  
Plasma Growth Hormone ◽  
Hormone Levels ◽  
The Mean

ABSTRACT The effects of the infusion in four different dosages (0.001, 0.005, 0.02 and 0.2 mg/kg/min during 60 min) of cyclic 3′,5′-adenosine monophosphate and of its dibutyryl derivative on plasma growth hormone and on glucose, immunoreactive insulin and cortisol were studied in 38 normal subjects and in 10 patients with idiopathic hypopituitarism. In normal subjects cyclic 3′,5′-adenosine monophosphate provokes an increase in plasma growth hormone levels (only when a dosage of 0.2 mg/kg/min is used) without any changes in plasma glucose, insulin and cortisol. The maximal value of the means is observed 75 min after starting the infusion. Dibutyryl cyclic 3′,5′-adenosine monophosphate (0.2 and 0.02 mg/kg/min) provokes a dose-related rise in plasma growth hormone levels which is always preceded by hyperglycaemia and hyperinsulinaemia. The peak of the mean growth hormone levels occurs at 135 min after initiation of the infusion. In all but one hypopituitary patients the nucleotides do not promote growth hormone secretion. It is concluded that exogenous cyclic 3′,5′-adenosine monophosphate and its dibutyryl derivative may not be considered as analogous and that both compounds may contribute to study growth hormone release in normal subjects and in patients with growth abnormalities.

PARTIAL SOMATOTROPHIN INSUFFICIENCY IN CUSHING'S SYNDROME

1969 ◽  
Vol 60 (1) ◽  
pp. 121-129 ◽  
Author(s):  
G. Strauch ◽  
E. Modigliani ◽  
P. Luton ◽  
H. Bricaire
Keyword(s):  
Growth Hormone ◽  
Cushing’S Syndrome ◽  
Selective Inhibition ◽  
Cushing's Syndrome ◽  
Glucose Load ◽  
Plasma Growth Hormone ◽  
Arginine Infusion ◽  
Hormone Levels

ABSTRACT Plasma growth hormone levels were studied in 15 patients with Cushing's syndrome using several stimuli. All tests except one, were performed before treatment. No change occurred in 6 patients during acute hypoglycaemia and in 11 out of 13 after a glucose load. Arginine given intravenously to 11 subjects elicited a rise in 7 out of 8 females and 1 out of 3 males. From patients who responded to arginine infusion, 6 were insensitive to one or two of the above mentioned stimuli. A selective inhibition of the releasing mechanisms might account for the partial somatotrophin insufficiency found in Cushing's syndrome.

Sign in / Sign up

Export Citation Format

Share Document